Literature review article
Topic: Impact of Telemedicine in Inflammatory Bowel Disease
citations using endnote ; paper should contain headings: abstract, introduction, literature review, methodology, discussion and conclusion
BMI 502 ANNOTATED BIBILIOGRAPHY
1. Yin, A. L., Hachuel, D., Pollak, J. P., Scherl, E. J., & Estrin, D. (2019). Digital Health
Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review. Journal of
medical Internet research, 21(8), e14630. https://doi.org/10.2196/14630
This article is a scoping review that aims to identify and evaluate digital health apps in the
clinical care of inflammatory bowel disease (IBD). The authors searched various databases for
studies that investigated the use of digital health apps in IBD care. The review found that digital
health apps have the potential to improve self-management and clinical outcomes for IBD
patients. However, the authors also note that the current evidence is limited, and more rigorous
studies are needed to evaluate the effectiveness of these apps.
2. Aguas, M., Del Hoyo, J., Faubel, R., Valdivieso, B., & Nos, P. (2017). Telemedicine in
the treatment of patients with inflammatory bowel disease. Telemedicina en el manejo de
pacientes con enfermedad inflamatoria intestinal. Gastroenterologia y hepatologia, 40(9),
641–647. https://doi.org/10.1016/j.gastrohep.2017.07.001
This article reviews the use of telemedicine in the treatment of patients with IBD. The authors
describe various telemedicine technologies and their applications in IBD care, including remote
consultations, telemonitoring, and teleeducation. They also discuss the potential benefits and
challenges of telemedicine in IBD care, such as improving access to care, reducing healthcare
costs, and maintaining patient privacy. Overall, the authors suggest that telemedicine can
improve the quality of care for IBD patients, particularly in rural or remote areas.
3. de Jong, M. J., van der Meulen-de Jong, A. E., Romberg-Camps, M. J., Becx, M. C.,
Maljaars, J. P., Cilissen, M., van Bodegraven, A. A., Mahmmod, N., Markus, T.,
Hameeteman, W. M., Dijkstra, G., Masclee, A. A., Boonen, A., Winkens, B., van
Tubergen, A., Jonkers, D. M., & Pierik, M. J. (2017). Telemedicine for management of
inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised
controlled trial. Lancet (London, England), 390(10098), 959–968.
https://doi.org/10.1016/S0140-6736(17)31327-2
This article describes a randomized controlled trial of telemedicine for the management of IBD.
The authors developed a telemedicine platform called myIBDcoach, which provided remote
monitoring, self-management education, and communication with healthcare providers. The
study found that the myIBDcoach platform was effective in improving patient outcomes,
including quality of life, medication adherence, and disease control. The authors suggest that
telemedicine can enhance the management of IBD and reduce the burden on healthcare systems.
4. Siegel C. A. (2020). Management of Inflammatory Bowel Disease With Telemedicine.
Gastroenterology & hepatology, 16(10), 526–528.
This article provides an overview of telemedicine in the management of IBD. The author
discusses the benefits and challenges of telemedicine, including the potential to improve access
to care, reduce healthcare costs, and increase patient satisfaction. The author also notes the
importance
5. Fazal, F., Ur Rehman, M. E., Asif, O., Mustafa, H., Tanveer, U., Haider, T., Khalid, A.
R., Saeed, S., & Basit, J. (2022). Telemedicine: A promising future for inflammatory
bowel disease management. Annals of medicine and surgery (2012), 82, 104684.
https://doi.org/10.1016/j.amsu.2022.104684
Fazal et al. (2022) discusses the potential of telemedicine in managing inflammatory bowel
disease (IBD). The authors review the current state of IBD management, including its limitations
and challenges, and argue that telemedicine has the potential to improve patient outcomes,
increase access to care, and reduce healthcare costs. The article provides examples of
telemedicine applications, such as remote monitoring, teleconsultation, and tele-education, and
highlights their benefits and limitations. The authors also discuss the regulatory and ethical
considerations that need to be addressed to ensure the safe and effective use of telemedicine in
IBD management.
6. Rowan, C., & Hirten, R. (2022). The future of telemedicine and wearable technology in
IBD. Current opinion in gastroenterology, 38(4), 373–381.
https://doi.org/10.1097/MOG.0000000000000845
Rowan and Hirten (2022) provides an overview of the current state and future potential of
telemedicine and wearable technology in IBD management. The authors discuss the potential of
telemedicine to improve disease management, reduce healthcare costs, and increase patient
engagement. They also review the current state of wearable technology and its applications in
IBD management, including the use of sensors, mobile health apps, and virtual reality. The
article highlights the challenges that need to be addressed to ensure the effective integration of
telemedicine and wearable technology into clinical practice.
7. Atreja, A., Otobo, E., Ramireddy, K., & Deorocki, A. (2018). Remote Patient Monitoring
in IBD: Current State and Future Directions. Current gastroenterology reports, 20(2), 6.
https://doi.org/10.1007/s11894-018-0611-3
Atreja et al. (2018) reviews the current state and future directions of remote patient monitoring
(RPM) in IBD. The article discusses the potential of RPM to improve patient outcomes, increase
patient engagement, and reduce healthcare costs. The authors review the different types of RPM
technologies, such as telemonitoring, teleconsultation, and mobile health apps, and their
applications in IBD management. The article also highlights the regulatory and ethical
considerations that need to be addressed to ensure the safe and effective use of RPM in IBD
management.
8. George, L. A., Dominic, M. R., & Cross, R. K. (2020). Integration of telemedicine into
clinical practice for inflammatory bowel disease. Current opinion in gastroenterology,
36(4), 304–309. https://doi.org/10.1097/MOG.0000000000000647
George et al. (2020) provides a review of the integration of telemedicine into clinical practice for
IBD management. The article discusses the benefits and challenges of telemedicine in IBD
management, including its potential to improve access to care, increase patient engagement, and
reduce healthcare costs. The authors also review the different types of telemedicine technologies,
such as telemonitoring, teleconsultation, and tele-education, and their applications in IBD
management. The article provides examples of successful telemedicine programs and highlights
the challenges that need to be addressed to ensure the effective integration of telemedicine into
clinical practice.
9. Quinn, C. C., Chard, S., Roth, E. G., Eckert, J. K., Russman, K. M., & Cross, R. K.
(2019). The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD)
Clinical Trial: Qualitative Assessment of Participants’ Perceptions. Journal of medical
Internet research, 21(6), e14165. https://doi.org/10.2196/14165
Quinn et al. (2019) reports a qualitative assessment of participants’ perceptions of the
Telemedicine for Patients with Inflammatory Bowel Disease (TELE-IBD) clinical trial. The
article discusses the benefits and challenges of telemedicine in IBD management, including its
potential to improve access to care, increase patient engagement, and reduce healthcare costs.
The authors also review the different types of telemedicine technologies used in the TELE-IBD
trial, such as telemonitoring and teleconsultation, and their impact on patient outcomes. The
article provides insights into patients’ perceptions of telemedicine and their experiences with the
TELE-IBD trial.
10. Aguas Peris, M., Del Hoyo, J., Bebia, P., Faubel, R., Barrios, A., Bastida, G., Valdivieso,
B., & Nos, P. (2015). Telemedicine in inflammatory bowel disease: opportunities and
approaches. Inflammatory bowel diseases, 21(2), 392–399.
Aguas Peris et al. (2015) discusses the potential of telemedicine in IBD management and provide
an overview of its different applications, such as telemonitoring, teleconsultation, and teleeducation. The article discusses the benefits and challenges of telemedicine in IBD management,
including its potential to improve patient outcomes, increase access to care, and reduce
healthcare costs. The authors also review the regulatory and ethical considerations that need to
be addressed to ensure the safe and effective use of telemedicine in IBD management.
11. Michel, H. K., Maltz, R. M., Boyle, B., Donegan, A., & Dotson, J. L. (2021). Applying
Telemedicine to Multidisciplinary Pediatric Inflammatory Bowel Disease Care. Children
(Basel, Switzerland), 8(5), 315. https://doi.org/10.3390/children8050315
Michel et al. (2021) describes the implementation of a telemedicine program for
multidisciplinary pediatric inflammatory bowel disease (IBD) care. They found that the program
led to high satisfaction rates among patients and caregivers, improved access to care, and
reduced the need for in-person visits.
12. Zhen, J., Marshall, J. K., Nguyen, G. C., Atreja, A., & Narula, N. (2021). Impact of
Digital Health Monitoring in the Management of Inflammatory Bowel Disease. Journal
of medical systems, 45(2), 23. https://doi.org/10.1007/s10916-021-01706-x
Zhen et al. (2021) conducted a literature review to assess the impact of digital health
monitoring in the management of IBD. They found that digital health interventions such as
telemedicine and mobile apps can improve disease outcomes, patient satisfaction, and
medication adherence. However, they also noted that further research is needed to fully
understand the long-term benefits of these interventions.
13. Majidova, K., Handfield, J., Kafi, K., Martin, R. D., & Kubinski, R. (2021). Role of
Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping
Review. Genes, 12(10), 1465. https://doi.org/10.3390/genes12101465
Majidova et al. (2021) conducted a scoping review to explore the role of digital health and
artificial intelligence in IBD. They found that digital health interventions such as telemedicine,
mobile apps, and wearables can improve patient outcomes and provide valuable data for
personalized medicine. However, they also highlighted the need for further research to evaluate
the effectiveness of these interventions and address potential privacy and ethical concerns.
14. Cross, R. K., Jambaulikar, G., Langenberg, P., Tracy, J. K., Collins, J. F., Katz, J.,
Regueiro, M., Schwartz, D. A., & Quinn, C. C. (2015). TELEmedicine for Patients with
Inflammatory Bowel Disease (TELE-IBD): Design and implementation of randomized
clinical trial. Contemporary clinical trials, 42, 132–144.
https://doi.org/10.1016/j.cct.2015.03.006
Cross et al. (2015) describes the design and implementation of the TELEmedicine for Patients
with Inflammatory Bowel Disease (TELE-IBD) randomized clinical trial. The study aimed to
assess the feasibility and effectiveness of a telemedicine program for IBD care. They found that
the program was feasible and well-received by patients, but further research is needed to fully
evaluate its impact on disease outcomes.
15. Cross, R. K., Langenberg, P., Regueiro, M., Schwartz, D. A., Tracy, J. K., Collins, J. F.,
Katz, J., Ghazi, L., Patil, S. A., Quezada, S. M., Beaulieu, D., Horst, S. N., Russman, K.,
Riaz, M., Jambaulikar, G., Sivasailam, B., & Quinn, C. C. (2019). A Randomized
Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease
(TELE-IBD). The American journal of gastroenterology, 114(3), 472–482.
https://doi.org/10.1038/s41395-018-0272-8
Cross et al. (2019) reports the results of the TELE-IBD randomized controlled trial, which aimed
to assess the effectiveness of a telemedicine program for IBD care. They found that the program
led to improved disease outcomes and patient satisfaction, and reduced healthcare utilization and
costs. The study suggests that telemedicine can be an effective way to provide IBD care,
especially for patients in rural or underserved areas.
16. Saunders A, Hill L, Popov J, Kalantar M, Farbod Y, Tewari P, Chauhan U. The role of
telemedicine in the management of inflammatory bowel disease: a systematic review
protocol. Minerva Gastroenterol (Torino). 2021 Jun 1. doi: 10.23736/S27245985.21.02939-9. Epub ahead of print. PMID: 34078035.
Saunders et al. (2021) describes a systematic review protocol for evaluating the role of
telemedicine in the management of IBD. The review will assess the impact of telemedicine on
disease outcomes, patient satisfaction, and healthcare utilization, and identify best practices for
implementing telemedicine programs.
17. Harris RJ, Downey L, Smith TR, Cummings JRF, Felwick R, Gwiggner M. Life in
lockdown: experiences of patients with IBD during COVID-19. BMJ Open
Gastroenterol. 2020 Nov;7(1):e000541. doi: 10.1136/bmjgast-2020-000541. PMID:
33214234; PMCID: PMC7677865.
Harris et al. (2020) reports the experiences of patients with IBD during the COVID-19 pandemic,
which led to increased use of telemedicine for IBD care. They found that patients appreciated the
convenience and safety of telemedicine, but also experienced challenges such as technological
difficulties and reduced access to in-person care.
18. Patil SA, Cross RK. Current Landscape of Telemedicine Practice in Inflammatory Bowel
Disease. Inflamm Bowel Dis. 2018 Aug 16;24(9):1910-1917. doi: 10.1093/ibd/izy113.
PMID: 29718218.
Patil and Cross (2018) provides an overview of the current landscape of telemedicine practice in
IBD. They describe various telemedicine modalities, such as videoconferencing, remote
monitoring, and mobile apps, and discuss the potential benefits and challenges of each approach.
19. Ankersen DV, Noack S, Munkholm P, Sparrow MP. E-Health and remote management
of patients with inflammatory bowel disease: lessons from Denmark in a time of need.
Intern Med J. 2021 Aug;51(8):1207-1211. doi: 10.1111/imj.15132. Epub 2021 Aug 3.
PMID: 34346152.
Ankersen et al. (2021) describes the use of e-health and remote management of patients with
IBD in Denmark during the COVID-19 pandemic. They found that telemedicine was effective in
providing care for patients with IBD and allowed for continuity of care during the pandemic.
20. Lim MH, McMahon A, Radford-Smith G. Delivering inflammatory bowel disease care
across distance. Intern Med J. 2022 Mar;52(3):411-417. doi: 10.1111/imj.15068. PMID:
32975818; PMCID: PMC7537200.
Lim et al. (2022) discusses the challenges and opportunities associated with delivering IBD care
across distance, such as through telemedicine. They describe various telemedicine programs
implemented in Australia and highlight the importance of personalized care and patient-centered
approaches in remote IBD care.
Format for a Scientific Term Paper
ABSTRACT
A short (1/2 page) description of the paper. Summarize the issue or problem that you are
researching, and explain why it is important and/or interesting, and briefly review your findings.
INTRODUCTION
Describe the issue or problem that you are researching.
LITERATURE REVIEW
Conduct a literature search using PubMed, Ovid Medline, Google Scholar, or a related database.
All databases are available from the UB Libraries. The literature search will enable you to
determine the current thinking, and research being conducted on the topic, and the
significance of the problem.
METHODS
Your literature search is the first step in preparing the methods section of the paper. The
search functions as the roadmap for finding information and/or data on your topic. Save your
search strategy as you are required to submit a copy of it to the instructors.
The second step in your methods section is to conduct a critical appraisal of the literature that
you found. Please appraise the articles for the relevance, validity, reliability, and applicability of
the data you collected to the research paper you are writing.
RESULTS
In this section you will describe your findings. For example, did you identify a substantial
amount of information to effectively answer the questions posed in the introduction?
DISCUSSION and CONCLUSIONS
Summarize the most important findings from your research. What conclusions can you draw?
How do your results fit into a broader context?